Scipac Ltd
June 20th, 2008 — adminBroad Oak Road
ME9 8AQ Sittingbourne, Kent
United Kingdom
Phone: (+44-1795)423077
Fax: (+44-1795)426942
http://www.scipac.com
mail@scipac.com
Company Profile
About us
Scipac Ltd was founded by Dr Clive Dawes and Tony Raeside, who first studied chemistry together in the early seventies. They associated their technical and financial experience and began trading in 1985, offering a complete SCIentific PACkage to the Diagnostics Industry.
Through the years Scipac has developed a comprehensive product range of purified Human Antigens, Serum/Plasma products and Magnetisable Particles. Scipac now also provides Transferrin for Cell Culture use.
Scipac employs 35 people in its own laboratory premises. The Company operates a quality management system which complies with the requirements of BS EN ISO 9001:2000 and has been registered with the British Standard Institute (BSI) since January 1993. Now progressively upgrading standards even further with ISO13485 accreditation already in place for two labs and more to come.
Sadly, Scipac lost one of his founders, Tony raeside, in 2001. We have all been inspired by Tony and we will continue to operate in a way that will honour his memory.
Today, the business is growing faster than ever, approx. 350 products are available and 80% of our sales are made of products manufactured in our premises. Export represents 90% of our business, including 60% in the USA.
Product Information
03.01.04 Enzymes
Streptokinase 18.09.2007
Streptokinase is a thrombolytic agent i.e. it dissolves vascular thrombi. This potent agent is derived from the beta haemolytic streptococci and is consequently associated with the risk of anaphylaxis. The risk is dependent upon the level of the patient’s circulating anti-streptokinase antibodies. Streptokinase acts by stimulating the conversion of plasminogen to plasmin. Is a proteolytic enzyme which is able to disrupt fibrin stability and production.
03.01.04.01 Human enzymes
03.01.09 Equipment and systems for urinary diagnosis
03.01.09.02 Reagents for urinary diagnosis
03.01.10 Devices and systems for haemoglobin determination
03.01.10.06 Reagents for the determination of glycosylated haemoglobins
03.01.11 Controls / Standards / Calibrators clinical chemistry
03.01.11.01 Control material for the determination of glycosylated haemoglobins
03.01.12 Units and systems for dry chemistry
03.01.12.05 Reagents for clinical chemistry
03.02.03 Auto-immune diseases
03.02.04 Fertility/Pregnancy hormones/Proteins
03.02.05 Units and systems for hormone determination
03.02.05.04 Reagents for hormone determination
03.02.06 Thyroid function hormones
03.02.06.03 Control material for thyroid gland diagnostics
03.02.06.04 Reagents for thyroid gland diagnostics
03.02.08 Units and systems for the determination of immunoglobulins and plasma proteins
03.02.08.03 Control material for immunoglobulin and plasma protein determination
03.02.08.05 Reagents for immunoglobulin and plasma protein determination
03.02.12 Rheumatoid diseases
03.02.12.04 Reagents for diagnosis of rheumatism
03.02.14 Specific proteins
03.02.14.01 C-reactive proteins (CRP)
03.02.17 Tumor markers
03.02.17.03 Control material for tumour marker determination
03.02.17.04 Reagents for tumour marker determination
03.04.03 Controls / Standards / Calibrators - Microbiology
03.04.03.02 HbAIC control
03.05.02 Hepatitis Viruses
03.05.02.01 Infections desease antigens